Valeant Pharmaceuticals: How Much Downside? – Seeking Alpha

Valeant Pharmaceuticals: How Much Downside?
Seeking Alpha
Drug company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is not the highest quality company available to investors. Valeant has struggled with government and regulatory investigations, lost its chief executive officer, missed earnings …
Is Valeant Pharmaceuticals Playing With Fire?Bloomington Pantagraph
Valeant Pharmaceuticals Intl Inc Rises A lot Today, Is Now One of The Best PerformerPost News
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Performance OverviewNewburgh Press
Street Updates –Smаrt Stоck Nеws –share market updates (press release) –InvestorGuide
all 34 news articles »